Which GLP-1 medications does Anthem cover
Introduction Incretin-based therapies have become a cornerstone in the management of type 2 diabetes mellitus (T2DM) ( Beyond their glucose-lowering properties, GLP-1 RAs have been shown to exert anti-inflammatory and immunomodulatory effects through actions on immune cells and inflammatory signalling pathways
It asks whether the compound name, lot number, testing method, date, and lab source align with the product documentation
doi: 10.1007/s12325-018-0677-1 34 GranhallCDonsmarkMBlicherTMGolorGSndergaardFLThomsenMet al
Of the two incretin hormones, glucagon-like peptide-1 (GLP-1) has therapeutic potential to reduce body weight and plasma glucose levels
One of the more recent representatives of this drug class, and the one that has been shown to exert a superior effect to GLP-1 receptor agonists in humans, is LY3298176/tirzepatide, a synthetic linear peptide molecule containing 39 amino acids (Fig